Endogenous Heparin-Like Substances Significantly Impair Coagulation in Patients Undergoing Orthotopic Liver Transplantation
- 1 April 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 86 (4) , 691-695
- https://doi.org/10.1213/00000539-199804000-00002
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Use of heparinase modified thrombelastography in liver transplantationBritish Journal of Anaesthesia, 1997
- Heparinase-guided thrombelastography in an anticoagulated parturientBritish Journal of Anaesthesia, 1996
- Reversal of post-reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantationBritish Journal of Anaesthesia, 1994
- In Vitro Reversal of Heparin Effect with HeparinasAnesthesia & Analgesia, 1994
- Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assayJournal of Cardiothoracic and Vascular Anesthesia, 1994
- THE APPEARANCE OF DONOR HEPARIN IN THE RECIPIENT AFTER REPERFUSION OF A LIVER GRAFTTransplantation, 1993
- Plasma concentrations of endogenous heparinoids in portal hypertension.Gut, 1992
- Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinaseThrombosis Research, 1986
- Liver TransplantationSurgical Clinics of North America, 1985
- Anticoagulantly active heparin-like molecules from vascular tissueBiochemistry, 1984